Aimwell Partners Inc. (AIMN) News
Follow Aimwell Partners Inc. (AIMN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
AIMN - The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It
AIMN - The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It
NEWS | Sep 15, 2026, 12:30 PM UTC
L
AimwellBio Puts Its Global Intelligence Map in Public View, No Login Required, as Dr. Chris A. Jones Builds Out the Advisory Bench Behind it
Aimwell Partners Inc. (OTCID:AIMN) invites anyone to check the work at aimwellbio.com/atlas, confirms multiple physicians and prospective collaboration partners in active discussions following the Trustr acquisition, and
MNA | Sep 02, 2026, 12:30 PM UTC
L
AIMN - AimwellBio Puts Its Global Intelligence Map in Public View, No Login Required, as Dr. Chris A. Jones Builds Out the Advisory Bench Be
AIMN - AimwellBio Puts Its Global Intelligence Map in Public View, No Login Required, as Dr. Chris A. Jones Builds Out the Advisory Bench Behind it
EQUITY | Sep 02, 2026, 12:30 PM UTC
L
Aimwell Bio closes Trustr IP purchase, starts onboarding team
Aimwell Bio closed the Trustr IP purchase and says it is bringing aboard the people who built it.
MNA | Aug 27, 2026, 12:30 PM UTC
L
Aimwell Bio closes Trustr IP purchase
Aimwell Bio has closed the Trustr IP purchase and says it will begin onboarding the team that built it.
MNA | Aug 27, 2026, 12:30 PM UTC
L
AIMN - AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Boar
AIMN - AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors
EQUITY | Aug 17, 2026, 12:45 PM UTC
L
AimwellBio publishes investor briefing on $10m acquired IP portfolio
AimwellBio (AIMN) publishes an investor briefing on an acquired Trustr intellectual property portfolio valued at $10m, emphasizing transparency.
EQUITY | Aug 13, 2026, 01:00 PM UTC
L
AIMN - Aimwell Partners Announces Agreement in Principle to Acquire Intellectual Property Valued at Approximately $10 Million - Click For Re
AIMN - Aimwell Partners Announces Agreement in Principle to Acquire Intellectual Property Valued at Approximately $10 Million
MNA | Aug 06, 2026, 12:30 PM UTC